Not Enough Antibiotics in Drug Development Pipeline, WHO Says
Few in development are innovative enough to target critical, drug-resistant pathogens
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Few in development are innovative enough to target critical, drug-resistant pathogens
Only registered members have full access to PracticeUpdate content.